Julia Delahousse

Villejuif, 94805, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Sex differences in the pharmacokinetics of anticancer drugs: a systematic review.

Sex differences in the pharmacokinetics of anticancer drugs: a systematic review.

Journal: ESMO open

Published: June 11, 2024

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors.

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors.

Journal: Journal for immunotherapy of cancer

Published: April 23, 2024

Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network.

Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network.

Journal: Journal of endocrinological investigation

Published: March 26, 2024

"Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities".

"Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities".

Journal: Cancer letters

Published: March 18, 2024

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.

Journal: Frontiers in immunology

Published: July 31, 2023

Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review.

Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review.

Journal: Journal of pain and symptom management

Published: July 25, 2023

Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions.

Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions.

Journal: Expert opinion on drug metabolism & toxicology

Published: March 20, 2023

Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer.

Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer.

Journal: Cancers

Published: December 03, 2020

Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.

Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.

Journal: Leukemia & lymphoma

Published: October 12, 2020

Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects.

Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects.

Journal: Journal for immunotherapy of cancer

Published: June 16, 2020

Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies.

Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 10, 2019

Pharmacokinetics/Pharmacodynamic (PK/PD) relationship of therapeutic monoclonal antibodies used in oncology: what's new?

Pharmacokinetics/Pharmacodynamic (PK/PD) relationship of therapeutic monoclonal antibodies used in oncology: what's new?

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 10, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026